ConductScience.org, home

Paper28294492

High prevalence of willingness to use direct-acting antiviral-based regimens for hepatitis C virus (HCV) infection among HIV/HCV coinfected people who use drugs.

Socías ME and 6 others. HIV Med, 2017. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. High prevalence of willingness to use direct-acting antiviral-based regimens for hepatitis C virus (HCV) infection among HIV/HCV coinfected people who use drugs. Papers, record 28294492. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28294492

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
High prevalence of willingness to use direct-acting antiviral-based regimens for hepatitis C virus (HCV) infection among HIV/HCV coinfected people who use drugs.
PubMed
Journal
HIV Med
PubMed
Year
2017
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
0.6
iCite
Revised in PubMed
2026-01-27
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Socías MEM E
2Ti LL
3Dong HH
4Shoveller JJ
5Kerr TT
6Montaner JJ
7Milloy MJM-J

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiviral AgentsMajor topic
CoinfectionMajor topic
HIV InfectionsMajor topic
Hepatitis CMajor topic
Substance-Related DisordersMajor topic
Adult
Canada
Female
Humans
Male
Patient Compliance
Prevalence
Prospective Studies
Treatment Outcome

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 DA021525NIDA NIH HHSUnited StatesR01DA021525PubMed and NIHNIH RePORTER
R01 DA036307NIDA NIH HHSUnited StatesR01DA036307PubMed and NIHNIH RePORTER
R25 DA037756NIDA NIH HHSUnited StatesR25DA037756PubMed and NIHNIH RePORTER
U01 DA021525NIDA NIH HHSUnited StatesR01DA021525PubMed and NIHNIH RePORTER
U01DA021525NIHNIH RePORTER

Download CSV of grants

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115768339Factors associated with interest in initiating treatment for hepatitis C Virus (HCV) infection among young HCV-infected injection drug users.Clin Infect Dis2005https://conductscience.org/library/papers/15768339PubMed
223884064Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy.Clin Infect Dis2013https://conductscience.org/library/papers/23884064PubMed
326922272Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis.Lancet Infect Dis2016https://conductscience.org/library/papers/26922272PubMed
49707146Barriers to use of free antiretroviral therapy in injection drug users.JAMA1998https://conductscience.org/library/papers/9707146PubMed
525996567Effect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: the ETHOS study.J Viral Hepat2015https://conductscience.org/library/papers/25996567PubMed
623884071Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis.Clin Infect Dis2013https://conductscience.org/library/papers/23884071PubMed
715768340Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia.Clin Infect Dis2005https://conductscience.org/library/papers/15768340PubMed
818165889Limited uptake of hepatitis C treatment among injection drug users.J Community Health2008https://conductscience.org/library/papers/18165889PubMed
925042607Phylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver, Canada.Hepatology2014https://conductscience.org/library/papers/25042607PubMed
1023223596Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis.Clin Infect Dis2013https://conductscience.org/library/papers/23223596PubMed
118651235Reliability of self-reported human immunodeficiency virus risk behaviors in a residential drug treatment population.Am J Epidemiol1996https://conductscience.org/library/papers/8651235PubMed
1223205675Accessing Hepatitis C patients who are difficult to reach: it is time to overcome barriers.J Viral Hepat2012https://conductscience.org/library/papers/23205675PubMed
1323429381Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C virus-coinfected patients with compensated cirrhosis.Clin Infect Dis2013https://conductscience.org/library/papers/23429381PubMed
1424820257Hepatitis C virus-related knowledge and willingness to receive treatment among patients on methadone maintenance.J Addict Med2014https://conductscience.org/library/papers/24820257PubMed
1523391612The effect of stimulant use on antiviral treatment in an integrated hepatitis clinic.Gen Hosp Psychiatry2013https://conductscience.org/library/papers/23391612PubMed
1626248117Epidemiology of hepatitis C virus in HIV-infected patients.Curr Opin HIV AIDS2015https://conductscience.org/library/papers/26248117PubMed
1721499577Physicians' attitudes and practice toward treating injection drug users with hepatitis C: results from a national specialist survey in Canada.Can J Gastroenterol2011https://conductscience.org/library/papers/21499577PubMed
1826077144Evidence-based interventions to enhance assessment, treatment, and adherence in the chronic Hepatitis C care continuum.Int J Drug Policy2015https://conductscience.org/library/papers/26077144PubMed
1910405858The validity of drug users' self-reports in a non-treatment setting: prevalence and predictors of incorrect reporting methadone treatment modalities.Int J Epidemiol1999https://conductscience.org/library/papers/10405858PubMed
2024331294EASL Clinical Practice Guidelines: management of hepatitis C virus infection.J Hepatol2014https://conductscience.org/library/papers/24331294PubMed

See all 34 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
38487594Hepatitis C Virus Infection and Hospital-Related Outcomes: A Systematic Review.Can J Gastroenterol Hepatol2024https://conductscience.org/library/papers/38487594PubMed
37280588Accessing hepatitis C direct acting antivirals among people living with hepatitis C: a qualitative study.Int J Equity Health2023https://conductscience.org/library/papers/37280588PubMed
35893702Collaborative Referral Model to Achieve Hepatitis C Micro-Elimination in Methadone Maintenance Treatment Patients during the COVID-19 Pandemic.Viruses2022https://conductscience.org/library/papers/35893702PubMed
34556508Health programmes and services addressing the prevention and management of infectious diseases in people who inject drugs in Canada: a systematic integrative review.BMJ Open2021https://conductscience.org/library/papers/34556508PubMed
33902968"Stigma is where the harm comes from": Exploring expectations and lived experiences of hepatitis C virus post-treatment trajectories among people who inject drugs.Int J Drug Policy2021https://conductscience.org/library/papers/33902968PubMed
33740984"I want to get better, but…": identifying the perceptions and experiences of people who inject drugs with respect to evolving hepatitis C virus treatments.Int J Equity Health2021https://conductscience.org/library/papers/33740984PubMed
29679811Hepatitis C care continuum and associated barriers among people who inject drugs in Chennai, India.Int J Drug Policy2018https://conductscience.org/library/papers/29679811PubMed
29630030HIV Serostatus and Having Access to a Physician for Regular Hepatitis C Virus Care Among People Who Inject Drugs.J Acquir Immune Defic Syndr2018https://conductscience.org/library/papers/29630030PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
MLC123209PubTator's text mininghttps://conductscience.org/library/genes/23209NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28294492

GET https://conductscience.org/api/papers/v1/28294492/references?page=2